clinical trial · NCT05961592
R-2487 in Patients With Rheumatoid Arthritis
Arthritis, RheumatoidR-2487 DP
brief summary
The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-2487) in patients with Rheumatoid Arthritis. Patients will take an oral dosage of probiotic (R-2487) and physicians will assess and measure their Rheumatoid Arthritis. Blood and fecal evaluations of inflammation and assessment of probiotic (R-2487) on fecal level will also be measured.
started
Oct 19, 2023
primary completion
Nov 30, 2026
completion
Dec 31, 2026
last updated
Sep 23, 2025
official title
A Single and Repeat Dosing Study of the Safety, Drug Exposure and Clinical Activity of R-2487 in Patients With Rheumatoid Arthritis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol